Relatively high frequency of VWD types 3 and 2 in a cohort of Indian patients: The role of multimeric analysis [2]

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 6, 2005, Pages 1321-1323

  Gupta, P K ^a   Ahmed, R P H ^a   Sazawal, S ^a   Choudhry, V P ^a   Saxena, R ^a,b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

AUTOSOMAL DOMINANT INHERITANCE; BLEEDING DISORDER; BLEEDING TIME; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; INDIAN; LETTER; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; VON WILLEBRAND DISEASE; CLASSIFICATION; COHORT ANALYSIS; DIMERIZATION; INCIDENCE; INDIA;

COHORT STUDIES; DIMERIZATION; FEMALE; HUMANS; INCIDENCE; INDIA; MALE; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 24944588050     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01336.x     Document Type: Letter

References (17)

1. Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, Meyer D, Peake I, Rodeghiero F, Srivastava A. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84: 160-74.
2. Schneppenheim R, Thomas KB, Sutor AH. Von Willebrand disease in childhood. Semin Thromb Hemost 1995; 21: 261-75.
3. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand disease. Blood 1987; 69: 454-9.
4. Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994; 71: 520-3.
5. Sadler JE. Biochemistry and genetics of von Willebrand factor. Ann Rev Biochem 1998; 67: 395.
6. Mielke CH Jr, Kaneshiro MM, Maher IA, Weiner JM, Rapaport SI. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969; 34: 204-15.
7. Lewis SM, Bain BJ, Bater I. Practical Haematology, 9th edn. London: Churchill Livingstone, 2001.
8. Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J. Quantitative assay of a plasma factor deficient in von Willebrand disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. J Clin Invest 1973; 52: 2708-16.
9. Ruggeri ZM, Zimmerman TS. The complex multimeric composition of factor VIII / von Willebrand factor. Blood 1981; 57: 1140-3.
10. Enayat MS, Hill FGH. Analysis of the complexity of the multimeric structure of factor VIII related antigen/von Willebrand protein using a modified electrophoretic technique. J Clin Pathol 1983; 36: 915-19.
11. Federici AB, Castaman G, Mannucci PM. Guidelines for the diagnosis and management of von Willebrand disease in Italy. Italian Association of Hemophilia Centers (AICE). Haemophilia 2002; 8: 607-21.
12. Castaman G, Rodeghiero F. Current management of von Willebrand disease. Drugs 1995; 50: 602-14.
13. Tuddenham EGD. Willebrand factor and its disorders: an overview of recent molecular studies. Blood Rev 1989; 3: 251-62.
14. Lenk H, Nilsson IM, Holmberg L, Weissbach G. Frequency of different types of von Willebrand disease in the GDR. Acta Med Scand 1988; 224: 275-80.
15. Hoyer LW, Rizza CR, Tuddenham EG, Carta CA, Armitage H, Rotblat F. Willebrand factor multimer patterns in von Willebrand disease. Br J Haematol 1983; 55: 493-7.
16. Kasper CK. The Haemophilia Bulletin. August 4th issue. Los Angeles, CA: Orthopaedic Hospital, 2003.
17. Nitu-Whalley IC, Riddell A, Lee CA, Pasi KJ, Owens D, Enayat MS, Perkins SJ, Jenkins PV. Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling. Thromb Haemost 2000; 84: 998-1004.